Ciglitazone—a human PPARγ agonist—disrupts dorsoventral patterning in zebrafish

Ciglitazone—a human PPARγ agonist—disrupts dorsoventral patterning in zebrafish

Peroxisome proliferator-activated receptor γ (PPARγ) is a ligand-activated transcription factor that regulates lipid/glucose homeostasis and adipocyte differentiation. While the role of PPARγ in adipogenesis and diabetes has been extensively studied, little is known about PPARγ function during early...

Full description

Bibliographic Details
Main Authors:	Vanessa Cheng, Subham Dasgupta, Aalekhya Reddam, David C. Volz
Format:	Article
Language:	English
Published:	PeerJ Inc. 2019-11-01
Series:	PeerJ
Subjects:	PPARγ Ciglitazone Dorsoventral patterning Zebrafish Embryo
Online Access:	https://peerj.com/articles/8054.pdf

Similar Items

Tris(1,3-dichloro-2-propyl) phosphate disrupts dorsoventral patterning in zebrafish embryos
by: Subham Dasgupta, et al.
Published: (2017-12-01)

Utilizing systems biology to reveal cellular responses to peroxisome proliferator-activated receptor γ ligand exposure
by: Vanessa Cheng, et al.
Published: (2021-01-01)

Effect of ciglitazone on adipogenic transdifferentiation of bovine skeletal muscle satellite cells
by: Junfang Zhang, et al.
Published: (2021-07-01)

Crosstalk between PPARγ Ligands and Inflammatory-Related Pathways in Natural T-Regulatory Cells from Type 1 Diabetes Mouse Model
by: S. Zulkafli Nor Effa, et al.
Published: (2018-11-01)

Lineage tracing shows that cell size asymmetries predict the dorsoventral axis in the sea star embryo
by: Vanessa Barone, et al.
Published: (2022-08-01)

PPAR-γ Modulators as Current and Potential Cancer Treatments
by: Tiange Chi, et al.
Published: (2021-09-01)

PPARγ ligand ciglitazone inhibits TNFα-induced ICAM-1 in human airway smooth muscle cells
by: Chien-Da Huang, et al.
Published: (2014-08-01)

BMP Signaling: Lighting up the Way for Embryonic Dorsoventral Patterning
by: Yifang Yan, et al.
Published: (2021-12-01)

PPARγ Agonists: Emergent Therapy in Endometriosis
by: Alexandre Vallée, et al.
Published: (2021-06-01)

Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease
by: Carmen Ciavarella, et al.
Published: (2020-04-01)

Optimized Structure-based Methodology for Studying PPARγ Partial Agonists
by: Merilin Al Sharif, et al.
Published: (2018-03-01)

Rnf220 is Implicated in the Dorsoventral Patterning of the Hindbrain Neural Tube in Mice
by: Yu-Bing Wang, et al.
Published: (2022-03-01)

Transcriptome Reveals Multi Pigmentation Genes Affecting Dorsoventral Pattern in Avian Body
by: Yang Xi, et al.
Published: (2020-10-01)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
by: Dongliang Fang, et al.
Published: (2022-01-01)

Obesity and the microbiome in atopic dermatitis: Therapeutic implications for PPAR-γ agonists
by: Jeremy P. McAleer
Published: (2023-03-01)

Potential of Natural Products in the Inhibition of Adipogenesis through Regulation of PPARγ Expression and/or Its Transcriptional Activity
by: Shi Feng, et al.
Published: (2016-09-01)

mRNA Expression and Role of PPARγ and PPARδ in Bovine Preimplantation Embryos Depending on the Quality and Developmental Stage
by: Katarzyna Suwik, et al.
Published: (2020-12-01)

Selective Tissue Distribution Mediates Tissue-Dependent PPARγ Activation and Insulin Sensitization by INT131, a Selective PPARγ Modulator
by: Xinni Xie, et al.
Published: (2017-05-01)

A Possible Modulator of Vitiligo Metabolic Impairment: Rethinking a PPARγ Agonist
by: Federica Papaccio, et al.
Published: (2022-11-01)

PPARγ agonist use and recurrence of atrial fibrillation after successful electrical cardioversion
by: Jun Gu, MD, PhD, et al.
Published: (2017-09-01)

Effects of peroxisome proliferator activated receptor gamma (PPARγ) agonist on fasting model applied neuron cultures
by: Pınarbaşı Arzu, et al.
Published: (2021-10-01)

Molecular docking studies on potential PPAR-γ agonist from Rhizophora apiculata
by: Gurudeeban Selvaraj, et al.
Published: (2014-07-01)

Dysregulation of the Amniotic PPARγ Pathway by Phthalates: Modulation of the Anti-Inflammatory Activity of PPARγ in Human Fetal Membranes
by: Audrey Antoine, et al.
Published: (2022-04-01)

Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model
by: Yuji Nakano, et al.
Published: (2020-07-01)

Influenza virus causes lung immunopathology through down-regulating PPARγ activity in macrophages
by: Hongbo Zhang, et al.
Published: (2022-08-01)

The Potential for Placental Activation of PPARγ to Improve the Angiogenic Profile in Preeclampsia
by: Brooke Grimaldi, et al.
Published: (2022-11-01)

SIRT7 regulates lipogenesis in adipocytes through deacetylation of PPARγ2
by: Fatema Akter, et al.
Published: (2021-10-01)

DHA increases adiponectin expression more effectively than EPA at relative low concentrations by regulating PPARγ and its phosphorylation at Ser273 in 3T3-L1 adipocytes
by: Jia Song, et al.
Published: (2017-08-01)

Identification of an irreversible PPARγ antagonist with potent anticancer activity
by: Youyi Peng, et al.
Published: (2020-12-01)

PPAR-γ Partial Agonists in Disease-Fate Decision with Special Reference to Cancer
by: Sangeeta Ballav, et al.
Published: (2022-10-01)

A proline-type fullerene derivative inhibits adipogenesis by preventing PPARγ activation
by: Megumi Funakoshi-Tago, et al.
Published: (2016-03-01)

The anti-fibrotic efficacy of adelmidrol depends on hepatic PPARγ levels
by: Huanyu Xiang, et al.
Published: (2023-09-01)

Development of PPARγ Agonists for the Treatment of Neuroinflammatory and Neurodegenerative Diseases: Leriglitazone as a Promising Candidate
by: Pilar Pizcueta, et al.
Published: (2023-02-01)

Bronchopulmonary Dysplasia: Crosstalk Between PPARγ, WNT/β-Catenin and TGF-β Pathways; The Potential Therapeutic Role of PPARγ Agonists
by: Yves Lecarpentier, et al.
Published: (2019-05-01)

Development of an In Vitro Screening Platform for the Identification of Partial PPARγ Agonists as a Source for Antidiabetic Lead Compounds
by: Lars Porskjær Christensen, et al.
Published: (2018-09-01)

Isoflavone Protects the Renal Tissue of Diabetic Ovariectomized Rats via PPARγ
by: Adriana Aparecida Ferraz Carbonel, et al.
Published: (2022-06-01)

PPARγ modulates long chain fatty acid processing in the intestinal epithelium
by: Duszka, Kalina, et al.
Published: (2018)

Rosiglitazone suppresses RANKL‐induced NFATc1 autoamplification by disrupting the physical interaction between NFATc1 and PPARγ
by: Kyeong‐Lok Park, et al.
Published: (2018-10-01)

Thymoquinone, a Dietary Bioactive Compound, Exerts Anti-Inflammatory Effects in Colitis by Stimulating Expression of the Colonic Epithelial PPAR-γ Transcription Factor
by: Balaji Venkataraman, et al.
Published: (2021-04-01)

Understanding PPARγ and Its Agonists on Trophoblast Differentiation and Invasion: Potential Therapeutic Targets for Gestational Diabetes Mellitus and Preeclampsia
by: Yushu Qin, et al.
Published: (2023-05-01)